SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24

SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24 Share Price

DE000SU7GDE1

Real-time Boerse Frankfurt Warrants 02:18:52 05/06/2024 pm IST
0.98 ^EUR	-2.97%

Current month	+57.81%
1 month	+359.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart VERTEX PHARMACEUTICALS INCORPORATED

Chart SG/CALL/VERTEX PHARMACEUTICALS/540/0.1/20.09.24

Latest news about VERTEX PHARMACEUTICALS INCORPORATED

Vertex Pharmaceuticals Incorporated : 2024 VRTX William Blair Growth Stock Conference Presentation vFinal	05/06	PU
Transcript : Vertex Pharmaceuticals Incorporated Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 04:00 PM	05/06
Vertex Pharmaceuticals Insider Sold Shares Worth $2,033,159, According to a Recent SEC Filing	04/06	MT
BMO Capital Adjusts Price Target on Vertex Pharmaceuticals to $500 From $480	31/05	MT

More news

Quotes 5-day view

Date	Price	Change
05/24/05	0.98	-2.97%
04/24/04	1.01	+23.17%
03/24/03	0.82	+28.12%
31/24/31	0.64	+42.22%
30/24/30	0.45	-4.26%

Real-time Boerse Frankfurt Warrants

Last update June 05, 2024 at 02:18 pm IST

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	VERTEX PHARMACEUTICALS INCORPORATED
Issuer	Société Générale
WKN	SU7GDE
ISIN	DE000SU7GDE1
Date issued	25/01/2024
Strike	540 $
Maturity	20/09/2024 (108 Days)
Parity	10 : 1
Emission price	1.37 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	1.55 €
Lowest since issue	0.072 €
Spread	0.09 €
Spread %	8.41%

Company Profile

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).

Sector

More about the company